€9.36
1.08% day before yesterday
Xetra, Nov 01, 05:36 pm CET
ISIN
DE0005157101
Symbol
HNL
Index

Dr. Hönle Target price 2024 - Analyst rating & recommendation

Dr. Hönle Classifications & Recommendation:

Buy
100%

Dr. Hönle Price Target

Target Price €22.75
Price €9.36
Potential
Number of Estimates 2
2 Analysts have issued a price target Dr. Hönle 2025 . The average Dr. Hönle target price is €22.75. This is higher than the current stock price. The highest price target is
€26.50 183.12%
register free of charge
, the lowest is
€19.00 102.99%
register free of charge
.
A rating was issued by 2 analysts: 2 Analysts recommend Dr. Hönle to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Dr. Hönle stock has an average upside potential 2025 of . Most analysts recommend the Dr. Hönle stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Revenue Million € 106.34 97.55
15.96% 8.27%
EBITDA Margin -0.77% 7.02%
153.61% 1,010.37%
Net Margin -10.37% -1.49%
1.57% 85.63%

2 Analysts have issued a sales forecast Dr. Hönle 2024 . The average Dr. Hönle sales estimate is

€97.6m
Unlock
. This is
1.13% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€97.8m 0.87%
Unlock
, the lowest is
€97.3m 1.38%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €106m 15.96%
2024
€97.6m 8.27%
Unlock
2025
€110m 12.81%
Unlock
2026
€121m 9.81%
Unlock

2 Analysts have issued an Dr. Hönle EBITDA forecast 2024. The average Dr. Hönle EBITDA estimate is

€6.9m
Unlock
. This is
0.44% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€7.6m 11.44%
Unlock
, the lowest is
€6.1m 10.56%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €-820k 145.05%
2024
€6.9m 935.37%
Unlock
2025
€12.8m 86.13%
Unlock
2026
€17.7m 38.43%
Unlock

EBITDA Margin

2023 -0.77% 153.61%
2024
7.02% 1,010.37%
Unlock
2025
11.59% 65.10%
Unlock
2026
14.60% 25.97%
Unlock

2 Dr. Hönle Analysts have issued a net profit forecast 2024. The average Dr. Hönle net profit estimate is

€-1.5m
Unlock
. This is
73.12% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€-1.3m 75.34%
Unlock
, the lowest is
€-1.6m 70.70%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €-11.0m 17.27%
2024
€-1.5m 86.85%
Unlock
2025
€2.6m 280.00%
Unlock
2026
€6.1m 133.33%
Unlock

Net Margin

2023 -10.37% 1.57%
2024
-1.49% 85.63%
Unlock
2025
2.37% 259.06%
Unlock
2026
5.04% 112.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Earnings Per Share -1.82 -0.24
17.27% 86.81%
P/E negative
EV/Sales 1.08

2 Analysts have issued a Dr. Hönle forecast for earnings per share. The average Dr. Hönle <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€-0.24
Unlock
. This is
73.03% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€-0.22 75.28%
Unlock
, the lowest is
€-0.26 70.79%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €-1.82 17.27%
2024
€-0.24 86.81%
Unlock
2025
€0.43 279.17%
Unlock
2026
€1.01 134.88%
Unlock

P/E ratio

Current -10.57 146.39%
2024
-39.00 268.97%
Unlock
2025
21.77 155.82%
Unlock
2026
9.31 57.23%
Unlock

Based on analysts' sales estimates for 2024, the Dr. Hönle stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.07 23.57%
2024
1.08 0.97%
Unlock
2025
0.96 11.36%
Unlock
2026
0.87 8.94%
Unlock

P/S ratio

Current 0.58 39.58%
2024
0.58 1.15%
Unlock
2025
0.52 11.36%
Unlock
2026
0.47 8.94%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today